Description

COMPOSITION: 

Levofloxacin – 250 mg

Levofloxacin – 500 mg

Levofloxacin (Fluoroquinolones)

• Levofloxacin is a broad spectrum antibiotic belonging to the third generation of quinolones group 

• Extensive clinical data confirm the good tolerability profile of levofloxacin without the phototoxicity or hepatic and cardiac Adverse Effects found with some other newer fluoroquinolone drugs.

• It prevents DNA replication in bacteria leading to bacterial cell death, and it is mainly used as a second-line therapy for lung infection This drug is considered an important antibiotic in case of microorganism that is resistant to other class of antibacterial agents such as beta-lactam antibiotics; hence, its quality is critical in effective treatment (

• Levofloxacin is one of the leading fluoroquinolone agents that has 

• improved anti–gram-positive potency, 
• Pharmacokinetics/ Pharmacodynamics properties, 
• a proven clinical trial record (particularly for community acquired pneumonia [CAP]), and an excellent safety profile.

• Shown clinical efficacy in community acquired pneumonia, and an excellent safety profile—similar to that of gatifloxacin, and is at least as efficacious as the third-generation cephalosporins.